Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089856
Status:
TERMINATED
Last Update Posted:
2008-11-05
First Post:
2004-08-16
Brief Title:
GVAX Vaccine for Prostate Cancer vs Docetaxel Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor:
Cell Genesys
Organization:
Cell Genesys
Organization Data
Organization:
Cell Genesys
Class:
INDUSTRY
Study ID:
G-0029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cell Genesys
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Cell Genesys Inc
Old Organization:
Cell Genesys Inc